The report below gives a good overview of the first quarter M&A activity in the Healthcare Industry Sector. There were 189 completed North American-based Healthcare M&A deals in Q4 2019, according to FactSet Research Systems.
A notable middle-market transaction announced in Q4 was Charles River Laboratories International, Inc.’s [NYSE: CRL] acquisition of HemaCare Corporation [OTCMKTS: HEMA] for approximately $380 million in cash. The acquisition expands Charles River’s scientific capabilities in the emerging, high-growth cell therapy sector, creating a comprehensive cell therapy solution that can help developers and manufacturers advance their critical programs from discovery through commercialization.
- US consumer prices for medical care commodities, an indicator of healthcare costs, increased 0.6% in November 2019 compared to the same period in 2018.
- US consumer prices for medical care services, an indicator of profitability for healthcare services, rose 5.1% in November 2019 compared to the same month in 2018.
- Total US revenue for healthcare and social assistance rose 4.4% in the third quarter of 2019 compared to the previous year.
Posted by Daniel Sirvent.